Effect of tamsulosin versus pumpkin seed oil on clinical symptoms in patients with benign prostatic hyperplasia

Effect of tamsulosin versus pumpkin seed oil on clinical symptoms in patients with benign prostatic hyperplasia: a single-blind randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N340

Enrollment

Registered

2020-02-19

Start date

2019-08-23

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hypertrophy. Benign neoplasm of prostate

Interventions

Intervention 1: Control group: Tamsulosin capsule 0.4 mg (manufactured by Tasnim Pharmaceutical Co.) once every night for 3 months. Intervention 2: Control group: Tamsulosin capsule 0.4 mg (manufactur

Eligibility

Sex/Gender

Male

Age

50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Age of 50 to 90 years, Benign prostatic hypertrophy

Exclusion criteria

Exclusion criteria: Indication of surgery, Taking medications for treatment of benign prostatic hypertrophy in the past 6 months

Design outcomes

Primary

Measure	Time frame
Clinical symptoms. Timepoint: Before the intervention and then monthly for 3 months. Method of measurement: By taking history.;Measuring prostate. Timepoint: Before the intervention and 3 months later. Method of measurement: By sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nikan Zerafatjoo

Hamedan University of Medical Sciences

nikan_z@yahoo.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 21, 2026